Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 23, 16:00
2648.10
18.65 (0.71%)
VOLUME 20,843
LIVE
NSE
Jun 23, 15:56
2643.70
8.1 (0.31%)
VOLUME 232,808
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Stocks in the news: Dr Reddy's, Glenmark, Reliance Defence, Ramky Infra, Petronet LNG 

8.15 am | 22 Jun 2017 |  Source: CNBC-TV18

Dr Reddy's Labs | Sun Pharma | Lupin | Glenmark Pharma | Coal India | Reliance Defence | Ramky Infra | Idea Cellular | Petronet LNG | Prism Cement...

Dr.Reddy's says scouting for in-licensing opportunities to expand specialty portfolio

9.44 pm | 20 Jun 2017 |  Source: Moneycontrol.com

“While we develop novel agents ourselves, we continue to seek licensing and development opportunities with third parties to further expand our produ...

Dr Reddy's may file two new drugs with FDA by 2019

2.35 pm | 20 Jun 2017 |  Source: PTI

According to filing with the US Securities and Exchange Commission, the city-based pharma company is expected to file the New Drug Application (NDA) w...

Indian pharma companies should increase base of sales in next few years: Nirmal Bang 

9.58 am | 19 Jun 2017 |  Source: CNBC-TV18

Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-...

Dr.Reddy's gets one USFDA observation for its Srikakulam formulation plant

9.52 pm | 16 Jun 2017 |  Source: Moneycontrol.com

“We have been issued a Form 483 with one observation, which we are addressing,” the company said....

Remain invested in Dr Reddy's Laboratories: Prakash Gaba 

3.30 pm | 16 Jun 2017 |  Source: CNBC-TV18

According to Prakash Gaba of prakashgaba.com, one may remain invested in Dr Reddy's Laboratories....

India Inc's overseas investment drops 56% in May

6.35 pm | 15 Jun 2017 |  Source: PTI

India Inc's foreign investment witnessed a sharp 56 percent decline at USD 1.26 billion in May this year....

Buy Dr Reddy's Laboratories, sell Exide Industries: Mitessh Thakkar 

3.00 pm | 15 Jun 2017 |  Source: CNBC-TV18

Mitessh Thakkar of mitesshthakkar.com suggests buying Dr Reddy's Laboratories and selling Exide Industries....

Dr Reddy’s US FDA developments get a thumbs up from brokerages

1.32 pm | 15 Jun 2017 |  Source: Moneycontrol.com

Cite positive news on the regulatory front, but pain for Duvvada plant may remain, they say....

Dr Reddy's recalls 3.25L cartons Cipla-made acne drug from US

2.47 pm | 14 Jun 2017 |  Source: PTI

The drug is manufactured by pharma firm Cipla at its Pune facility for Dr Reddy's Laboratories....

USFDA gives EIR to Dr Reddy's Laboratories API plant in Telangana

2.21 pm | 14 Jun 2017 |  Source: PTI

"In that regard, we would now like to inform you that we have received an establishment inspection report (EIR) from the USFDA today as closure of aud...

Buy Dr Reddy's Laboratories on dips: Sudarshan Sukhani 

11.12 am | 14 Jun 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises buying Dr Reddy's Laboratories....

Dr Reddy's up 2% on establishment inspection report from USFDA for Miryalaguda unit

10.05 am | 14 Jun 2017 |  Source: Moneycontrol.com

Dr Reddy's Labs received establishment inspection report from the US health regulator for its Miryalaguda plant....

Big relief comes from US drug regulator for DRL's API plant 

8.26 am | 14 Jun 2017 |  Source: CNBC-TV18

A spotlight on Dr. Reddy's Laboratories (DRL), a big relief comes in from the US drug regulator for its active pharmaceutical ingredients (API)...

Dr.Reddy's gets EIR for Miryalaguda plant, indicating closure of USFDA audit

10.49 pm | 13 Jun 2017 |  Source: Moneycontrol.com

The plant was inspected by USFDA from February 13-21 and had received three Form 483 Observations from US FDA. Miryalaguda plant called at CTO Unit V ...

Buy, Sell, Hold: 3 stocks and 3 sectors are being tracked by analysts today

8.26 am | 12 Jun 2017 |  Source: CNBC-TV18

Tata Motors, Axis Bank, pharma and telecom, among others are on the radar of investors on Monday....

Six in Sixty: Stocks you should keep on your radar 

2.45 pm | 08 Jun 2017 |  Source: CNBC-TV18

CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on....

Dr Reddy's Laboratories launches Bivalirudin injection

12.50 pm | 06 Jun 2017 |  Source: PTI

In a BSE filing, Dr Reddy's said it has "launched Bivalirudin for injection, 250 mg/vial, a therapeutic equivalent generic version of Angiomax for...

Positive on pharma; buy Dr Reddys, Cipla, Aurobindo: Rahul Arora 

4.24 pm | 26 May 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities, shared his views on various stocks and sectors....

Hold Dr Reddy's Laboratories; target of Rs 2450: Axis Direct

3.51 pm | 22 May 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Dr Reddy's Laboratories with a target price of Rs 2450 in its research report dated May 18, 2017....

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.